+ All Categories
Home > Documents > Management on Adnexal Mass

Management on Adnexal Mass

Date post: 08-Nov-2014
Category:
Upload: hossamaldin-hussein-kamel-salem
View: 61 times
Download: 5 times
Share this document with a friend
Description:
role of US in adnexial masses
Popular Tags:
209
Management on Adnexal Mass Prof HOSSAM HUSSEIN
Transcript
Page 1: Management on Adnexal Mass

Management on Adnexal Mass

Prof HOSSAM HUSSEIN

Page 2: Management on Adnexal Mass

Causes of Adnexal Masses

CancerBenign neoplasmsInfection (Abscess)Edematous Ovary secondary to torsionEndometriosisGI conditionsCorpus Luteum

Page 3: Management on Adnexal Mass

Causes of Adnexal Masses

Follicles and Follicular cystsHydrosalpinxPeduculated LeiomyomasPregnanciesHemorrhageAppendicitis

Page 4: Management on Adnexal Mass

Symptoms of An Adnexal Mass

NonePain/Abdominal discomfortGI symptomsUrinary symptomsPelvic pressure/BloatingBackache

Page 5: Management on Adnexal Mass

Symptoms of An Adnexal Mass

EdemaDVT/PEElectrolyte abnormalityAcute abdomenLarge Mass

Page 6: Management on Adnexal Mass

Discovery of Adnexal Mass

On yearly pelvic examPelvic exam for specific complaintUltrasoundCT (usually a serendipitis finding)MRIOther radiologic test

Page 7: Management on Adnexal Mass

Discovery of an Adnexal Mass

Serologic abnormalitySeen grosslyDuring surgery for an unrelated complaint

Page 8: Management on Adnexal Mass

Adnexal MassesThe following aspects of an adnexal mass should be evaluated.

Mobility – the mass should be moved by the vaginal probe or by the hand of the operator that is resting on the abdomen (‘sliding organs’ sign).Pain – its location should be established by watching the on-screen picture when touching different organs with the tip of the transvaginal probe.Wall structure – features of an ovarian mass, such as thickness and outer and inner surface irregularities and papillae, should be described and measured.Septations – the thickness of the septations should be reported.Echogenicity of the mass – the mass can be completely sonolucent and may have low-level echogenic contents, may be with or without an echogenic core, may have mixed echogenicity containing all of these components or may be completely echogenic.

Page 9: Management on Adnexal Mass

Adnexal MassesThe presence of the following conditions may make it more difficult to detect

ovarian or adnexal masses with ultrasonography.

Fluid-filled loop of bowelFaeces in loop of bowelClosed-loop bowel obstructionArtifact of multipath reflection of sound waves (stratified echo pattern resulting from echoes bouncing back and forth) from fluid-filled structure (e.g. bladder)Mesenteric cystsPeritoneal inclusion cysts (postoperative or after infections)Nabothian cystsHydrosalpinges (acute and chronic)Large fibroids.

Page 10: Management on Adnexal Mass

What is the goal of management of the adnexal Mass?

Rule out CancerAlleviate symptomsDetermine long term problems (i.e.; fertility, chronic pain, recurrence, and long term treatment)When to not intervene (over test or treat)

Page 11: Management on Adnexal Mass

Ovarian Cancer

Age

40

75

Incidence

15/100,000

54/100,000

Page 12: Management on Adnexal Mass

Risk Factors for Ovarian Cancer

Age (risk increases with age)NulliparityAncestry (American, Northern European, and Ashkenazi Jews)Personal history(only 10% are familial)Endometrial cancerBreast Cancer

Page 13: Management on Adnexal Mass

Risk Factors for Ovarian Cancer

?Fertility DrugsUse of Oral Contraceptives ( the longer the use the more protective it is the relative risk after 10 years use is 0.2)Tubal Ligation is protectiveHysterectomy is protective but BSO does not eliminate the risk

Page 14: Management on Adnexal Mass

Evaluation of an Adnexal Mass

HistoryPhysical/ PAPUltrasoundCA125 (+/- LDH,AFP,Inhibin)HCG, CBCLaparoscopy/Laparotomy

Page 15: Management on Adnexal Mass

Ultrasound Exam

Solid mass/ or complex massCystic Mass(unilocular more likely benign)Size (5-6cm in young patient repeat scan 4-6 weeks)Complex mass can be seen with corpus luteum or hemorrhagic cystDoppler flow/Pulsitile index

Page 16: Management on Adnexal Mass

Ultrasound

Pulsitility index of less than 0.4 is indicative of malignancy (experimental)Associated findings (ascites, fibroids,or endometrial abnormalities)

Page 17: Management on Adnexal Mass

Labs

CBC-looking for evidence of PID or anemiaSed Rate- non specific but best test for PIDHCG- rule out pregnancy is any reproductive age women (also a tumor marker for germ cell tumors of the ovary and hydatidiform mole)

Page 18: Management on Adnexal Mass

Labs

CA125- Tumor marker present in 80% of advanced ovarian cancers (less than 50% of stage I cancers)Unfortunately can be elevated in endometriosis, menses, infection, fibroids, liver or renal failure, ascites, breast cancer, endometrial and cervical cancers and GI malignancies

Page 19: Management on Adnexal Mass

Management based on:

Age of patientSize of massUltrasound description of cystic or complex or solidOther associated finding i.e, ascites, pulmonary effusion, lymphadenopathy, other cancers (cervix, endometrium, breast)

Page 20: Management on Adnexal Mass

Management under age 30

Cystic or complexLess than 6cmSuppress with birth control pills and/ or repeat ultra sound in 4-6 weeksIf persistent laparoscopy with probable ovarian cystecomyGreater than 12cm- surgery

Page 21: Management on Adnexal Mass

Management under age 30

Cystic 6-10cm can repeat ultrasound or proceed to surgerySolid mass greater than 6cm surgeryGrey area complex 6-8cm

Page 22: Management on Adnexal Mass

Management over 40 to 50

Cystic less than 6cm repeat ultrasound 4-6 weeks +/- suppressionComplex greater than 6-8cm- CA125 if elevated proceed to surgery if normal possibly repeat scan 4-6 weeksSolid greater than 6 cm- CA125 and surgery

Page 23: Management on Adnexal Mass

Benign Conditions of the Adnexa

Hydrosalpinx-Rx antibiotics re-assess TOA- IV antibiotics (Cefotetan plus vibramycin or Clindamycin plus Gentamycin) re-assess 4 weeks if no recurrence of Sx no further Rx if recurrent possible TAH BSO after repeat course of antibiotics. It may be necessary to do laparoscopy to establish diagnosis

Page 24: Management on Adnexal Mass

Benign conditions of the Adnexa

Endometriosis- to establish the diagnosis requires laparoscopy Rx- Lupron(GnRh agonist), Progesterones, Danazol (anti estrogen), Birth control pills either cyclic or continuous, or surgeryOvarian cystectomy if child bearing to be preserved, with excision or ablation of endometriosis

Page 25: Management on Adnexal Mass

Benign conditions of the Adnexa

Hemorrhagic cyst-usually manage with narcotic analgesics, usually self limiting 2-4 weeks, occasionally surgical intervention needed (again preserve ovary if child bearing wanted)Suppression with OC’s acceptable

Page 26: Management on Adnexal Mass

Corpus Luteum with or without hemorrhage-Narcotic analgesics +/- BCP’sRare surgeryEctopic pregnancy-Surgery or methotrexatePedunculated fibroids- No Rx if small-surgical removal if large or symptomatic

Benign Conditions of the Adnexa

Page 27: Management on Adnexal Mass

Benign Conditions of the Adnexa

Diverticular disease- Antibiotics for acute attacks, dietary changes and fiber, surgery if neededAppendicitis- SurgeryOvarian torsion- Oophorectomy occasionally detorsions

Page 28: Management on Adnexal Mass

Benign Conditions of the Adnexa

Para Tubal cysts- No RxFollicular cyst, Polycystic ovarian disease, and hyperstimulation of the ovary all managed conservatively

Page 29: Management on Adnexal Mass

Benign Conditions of the Adnexa

Benign cystic Teratoma (Dermoid Cyst)-Most common tumor in reproductive age women 25% of all ovarian neoplasms80% less than 10cm15% bilateral50% asymptomatic1-2% malignant transformation

Page 30: Management on Adnexal Mass

Cystic Teratoma cont

Complications include rupture, torsion, infection, hemorrhage, and malignant transformation, Thyrotoxicosis, autoimmune hemolytic anemia, and carcinoidTreatment- ovarian cystectomy or Oophorectomy(can wait until after -delivery if pregnant)

Page 31: Management on Adnexal Mass

Ovarian Cysts

What does this mean?FollicleCorpus luteumSerous cystadenomaMucinous cystadenoma

Page 32: Management on Adnexal Mass

Case #1

19yo GoPoAcute onset right sided pelvic painAfebrileWBC-8,000Never sexually active

Ultrasound shows a 5cm complex mass R adnexa Pelvic exam acutely tender no discharge

Page 33: Management on Adnexal Mass

Case #1

Most likely hemorrhagic corpus Treat with narcotic analgesicsConsider suppression with birth control pills

Page 34: Management on Adnexal Mass

Case # 2

32yo G3P3No symptomsYearly exam feel fullness left adnexa no tenderness HCG neg

Ultrasound exam shows multiple cysts in both ovaries largest 2.3cm R ovary 5cmX4.2cm, L ovary 4.6cmX3.9cm

Page 35: Management on Adnexal Mass

Case #2

Polycystic ovariesEither induce ovulation is pregnancy desired orSuppress with BCP’sDepending on other factors- labs Insulin, BS TSH, LH, FSH, Testosterone, DHEAS

Page 36: Management on Adnexal Mass

Case # 3

30yo G2P1ab1Mass left adnexa at yearly examNo SxHCG neg

Ultrasound shows 6cm complex mass with internal echoes (possible teratoma)

Page 37: Management on Adnexal Mass

Case # 3

These are fairly obvious on U/SSurgical removal by cystectomy in younger patients. Older patient oophorectomyThese are not emergency cases

Page 38: Management on Adnexal Mass

Case #4

26yo GoPoPt noticed weight gain and protuberant abdomenHCG negMass on exam to xyphoid , non tender

Ultrasound exam shows 26cm cystic mass with multiple septationsCA125- 5

Page 39: Management on Adnexal Mass

Case # 4

Usually one would suspect a mucinous cystadenomaThis patient had a huge hydrosalpinx Surgical removal

Page 40: Management on Adnexal Mass

Case #5

55yo G5P4C/O clothes not fitting well, fullness in lower pelvis, early satietyPelvic exam normal but limited do to pt mild obesity-

Ultrasound shows solid mass in R ovary 5cm L ovary not seenCA125-95CT normal

Page 41: Management on Adnexal Mass

Case # 5

Ovarian cancer

Page 42: Management on Adnexal Mass

Case #6

45yo G3P3Mild menorrhagiaYearly exam 10week size uterus with solid mass in L adnexaHCG neg

Ultrasound shows enlarged uterus with multiple fibroidsCA125- 40

Page 43: Management on Adnexal Mass

Case # 6

Pedunculated uterine fibroidTAHNo treatment

Page 44: Management on Adnexal Mass

Case #7

55yo G4P4PMBEndometrial biopsy atrophic endometrium

Ultrasound exam shows 4mm endometrium with 3cm unilocular cyst R adnexa

Page 45: Management on Adnexal Mass

Case #7

Benign cystRepeat U/S 4- 6 weeks if no change possibly recheck one more timeIf it changes laparoscopy possible laparotomy

Page 46: Management on Adnexal Mass

Case #8

23yo G3P1Severe pelvic pain onset 2 days prior to admissionWBC- 22,000Temp101HCG neg

Ultrasound exam shows 8cm complex mass L adnexaCA125-50+ rebound

Page 47: Management on Adnexal Mass

Case # 8

PID with tubo-ovarian abscessIV Clindamyacin and GentamyacinRepeat U/S 4-6 weeks

Page 48: Management on Adnexal Mass

Case #9

42yo G2P2Acute onset R lower pelvic painPelvic exam severe pain making exam poorWBC- 15,000Temp 101

Ultrasound exam shows 8cm mass in the R adnexa+ rebound

Page 49: Management on Adnexal Mass

Case # 9

Ovarian torsionOophorectomy

Page 50: Management on Adnexal Mass

Review

Ovarian “cysts” in reproductive age women are usually folliclesLess than 5cm in young patients can be reassessed in about 6 weeks Small unilocular cysts can be managed conservatively in most patientsCT’s are usually less accurate than ultrasound

Page 51: Management on Adnexal Mass

Review

CA125 is not a screening testIf the clinical picture does not match the finding on laboratory exams reassess

Page 52: Management on Adnexal Mass

Congenital Uterine Congenital Uterine AnomaliesAnomalies

3D Ultrasound is more accurate than 2D Ultrasound for diagnosing arcuate, subseptated,

septated and bicornuate uteri, but not for didelphys. It is very useful to determine the

dimensions of uterine septum, which may provide very useful information to surgeons

during hysteroscopy.

Page 53: Management on Adnexal Mass

Subseptate Uterus Complete Septate

Page 54: Management on Adnexal Mass

The two uterine bodies and the two endometrial cavities with similar dimensions and morphology are clearly distinguishable. E: endometrium.

Page 55: Management on Adnexal Mass
Page 56: Management on Adnexal Mass
Page 57: Management on Adnexal Mass

Fibroids

Page 58: Management on Adnexal Mass
Page 59: Management on Adnexal Mass
Page 60: Management on Adnexal Mass

Benign Ovarian

Page 61: Management on Adnexal Mass

Simple cyst Dermoid cyst clear fluid echogenic contentsSmooth wall nodule in cyst wall

Page 62: Management on Adnexal Mass
Page 63: Management on Adnexal Mass
Page 64: Management on Adnexal Mass

Haemorrahgic cyst

Page 65: Management on Adnexal Mass

Haemorrhagic cyst EndometriomaEchogenic contents thick wallResolves spontaneously

Page 66: Management on Adnexal Mass

Endometrioma

Page 67: Management on Adnexal Mass

Endometrioma in POD

Page 68: Management on Adnexal Mass

Endometrioma

Page 69: Management on Adnexal Mass

hyperstimulation

Page 70: Management on Adnexal Mass

The appearance of an ovary demonstrating multiple follicular development characteristic of ovarian hyperstimulation

syndrome

Page 71: Management on Adnexal Mass
Page 72: Management on Adnexal Mass
Page 73: Management on Adnexal Mass
Page 74: Management on Adnexal Mass

Hypo/anechoic cysts containing one or more hyperechoic nodules (“dermoid plug”), Cysts containing hyperechoic thin stripes and spots on a hypo/anechoic background (“starry sky” appearance

Page 75: Management on Adnexal Mass

dermoids

Page 76: Management on Adnexal Mass

Bening mucinious cystadenoma

Page 77: Management on Adnexal Mass

Ovarian fibroma

Page 78: Management on Adnexal Mass
Page 79: Management on Adnexal Mass
Page 80: Management on Adnexal Mass

A haemorrhage inside an ovarian cyst in a patient represented by acute abdomen

Page 81: Management on Adnexal Mass

Ultrasound in detecting early Ultrasound in detecting early ovarian carcinomaovarian carcinoma

Among ‘high-risk’ women (women with a family history of ovarian cancer or a personal history of

breast cancer) the sensitivity for detection of Stage I disease was 25% while the sensitivity for low-risk

women was 67 %.

This less-than-ideal sensitivity is not unexpected, because in many Stage I ovarian cancers, the

ovaries are neither enlarged nor morphologically abnormal.

Page 82: Management on Adnexal Mass

Ultrasound in detecting early Ultrasound in detecting early ovarian carcinomaovarian carcinoma

The use of color or Power Doppler imaging has not been shown to add significantly to the diagnosis of early-stage disease.

3-D volume acquisition and 3-D Power Doppler may help in the early identification of abnormal vascularity and architectural changes within

the ovary. Excrescences not seen by 2-D technology may be observed. While 3-D Power Doppler provides a new tool for measuring the quality of ovarian vascularity, its clinical value for the early detection of ovarian

carcinoma has yet to be determined. The efficiency of 3-D Power Doppler imaging in identifying Stage I ovarian cancer has yet to be

determined.

Page 83: Management on Adnexal Mass

The low annual prevalence of ovarian cancer within the general population, the large number of

women who must therefore be screened to identify a single ovarian cancer, and the poor sensitivity of

the test for Stage I disease make routine use of ultrasound for detection of ovarian cancer

impractical.

Page 84: Management on Adnexal Mass
Page 85: Management on Adnexal Mass

Vascular projection in a cyst

Surface rendering of a papillary in a cyst

Page 86: Management on Adnexal Mass
Page 87: Management on Adnexal Mass

Cont.

Page 88: Management on Adnexal Mass
Page 89: Management on Adnexal Mass

cont

Page 90: Management on Adnexal Mass

A 10 years old girl US shows a predominantly a solid tumor (Dysgerminoma)

Page 91: Management on Adnexal Mass

A granulosa cell tumor in 6 years old girl

Page 92: Management on Adnexal Mass

An immature teratoma with a apartially solid and cystic mass seen in 11 years girl

Page 93: Management on Adnexal Mass

Ovarian carcinoma note the solid and cystic nature

Page 94: Management on Adnexal Mass

Tubal

Page 95: Management on Adnexal Mass

A hydrosalpinx containing anechoic fluid and incomplete septation (s)

Page 96: Management on Adnexal Mass

The ‘beads-on-a-string’ sign (arrows) considered as additional evidence of the presence of hydrosalpinx.

Page 97: Management on Adnexal Mass

A hydrosalpinx showing a low level echoes within the distended fetal tube together with incomplete septations.

Page 98: Management on Adnexal Mass

The typical colour Doppler energy findings of hydrosalpinx

Page 99: Management on Adnexal Mass

Hydroalpinx

Page 100: Management on Adnexal Mass
Page 101: Management on Adnexal Mass
Page 102: Management on Adnexal Mass

Ectopic pregnancyEctopic pregnancyThe introduction of beta hCG testing and

transvaginal ultrasound has changed our approach to the patient suspected of an ectopic pregnancy.

Important advantage of the most currently used trans-vaginal transducers is the ability to perform simultaneous color and spectral Doppler studies,

allowing easy identification of the ectopic peritrophoblastic flow. Therefore, color Doppler may

be applied whenever a finding is suggestive of ectopic pregnancy.

Page 103: Management on Adnexal Mass

Ectopic pregnancy in Lt. tube Ectopic pregnancy in Lt. tube

Page 104: Management on Adnexal Mass

Ectopic gestational sac in the left adnexal region Ectopic gestational sac in the left adnexal region surrounded by a ring of fine near by vessels.surrounded by a ring of fine near by vessels.

Page 105: Management on Adnexal Mass

(TAS) Lt EP

Page 106: Management on Adnexal Mass
Page 107: Management on Adnexal Mass

Left EP

Page 108: Management on Adnexal Mass

Hetrotopic pregnancy

Page 109: Management on Adnexal Mass
Page 110: Management on Adnexal Mass
Page 111: Management on Adnexal Mass

Rt. interstitial ectopic pregnancy by 3-D trasnvaginal Rt. interstitial ectopic pregnancy by 3-D trasnvaginal sonographysonography

Page 112: Management on Adnexal Mass
Page 113: Management on Adnexal Mass

Rt inflammatory mass

Page 114: Management on Adnexal Mass
Page 115: Management on Adnexal Mass

Appendicular mass

Page 116: Management on Adnexal Mass
Page 117: Management on Adnexal Mass
Page 118: Management on Adnexal Mass
Page 119: Management on Adnexal Mass

Acutely inflamed appendix in deep pelvic position. The appendix could only be visualized with the help of a transvaginal probe

Page 120: Management on Adnexal Mass

Cecal carcinoma. US reveals asymmetric, hypoechoic, circumferential wall thickening of the cecum (arrowheads) with narrowing of the lumen. There is one pathologically enlarged lymph node.

Page 121: Management on Adnexal Mass

Thanks

Page 122: Management on Adnexal Mass
Page 123: Management on Adnexal Mass
Page 124: Management on Adnexal Mass
Page 125: Management on Adnexal Mass
Page 126: Management on Adnexal Mass
Page 127: Management on Adnexal Mass
Page 128: Management on Adnexal Mass

HOW TO ASSESS AN ADNEXEAL MASS USING US

PROF ABOUSHADY

Page 129: Management on Adnexal Mass
Page 130: Management on Adnexal Mass
Page 131: Management on Adnexal Mass
Page 132: Management on Adnexal Mass
Page 133: Management on Adnexal Mass
Page 134: Management on Adnexal Mass
Page 135: Management on Adnexal Mass
Page 136: Management on Adnexal Mass
Page 137: Management on Adnexal Mass
Page 138: Management on Adnexal Mass
Page 139: Management on Adnexal Mass
Page 140: Management on Adnexal Mass
Page 141: Management on Adnexal Mass
Page 142: Management on Adnexal Mass
Page 143: Management on Adnexal Mass
Page 144: Management on Adnexal Mass
Page 145: Management on Adnexal Mass
Page 146: Management on Adnexal Mass
Page 147: Management on Adnexal Mass
Page 148: Management on Adnexal Mass
Page 149: Management on Adnexal Mass
Page 150: Management on Adnexal Mass
Page 151: Management on Adnexal Mass
Page 152: Management on Adnexal Mass
Page 153: Management on Adnexal Mass
Page 154: Management on Adnexal Mass
Page 155: Management on Adnexal Mass
Page 156: Management on Adnexal Mass
Page 157: Management on Adnexal Mass
Page 158: Management on Adnexal Mass
Page 159: Management on Adnexal Mass
Page 160: Management on Adnexal Mass
Page 161: Management on Adnexal Mass
Page 162: Management on Adnexal Mass
Page 163: Management on Adnexal Mass
Page 164: Management on Adnexal Mass
Page 165: Management on Adnexal Mass
Page 166: Management on Adnexal Mass
Page 167: Management on Adnexal Mass
Page 168: Management on Adnexal Mass
Page 169: Management on Adnexal Mass
Page 170: Management on Adnexal Mass
Page 171: Management on Adnexal Mass
Page 172: Management on Adnexal Mass
Page 173: Management on Adnexal Mass
Page 174: Management on Adnexal Mass
Page 175: Management on Adnexal Mass
Page 176: Management on Adnexal Mass
Page 177: Management on Adnexal Mass
Page 178: Management on Adnexal Mass
Page 179: Management on Adnexal Mass
Page 180: Management on Adnexal Mass
Page 181: Management on Adnexal Mass
Page 182: Management on Adnexal Mass
Page 183: Management on Adnexal Mass
Page 184: Management on Adnexal Mass
Page 185: Management on Adnexal Mass
Page 186: Management on Adnexal Mass
Page 187: Management on Adnexal Mass
Page 188: Management on Adnexal Mass
Page 189: Management on Adnexal Mass
Page 190: Management on Adnexal Mass

The appearance of an ovary demonstrating multiple follicular development characteristic of ovarian hyperstimulation

syndrome

Page 191: Management on Adnexal Mass

Tubal

Page 192: Management on Adnexal Mass

A hydrosalpinx containing anechoic fluid and incomplete septation (s)

Page 193: Management on Adnexal Mass

Ectopic pregnancy in Lt. tube Ectopic pregnancy in Lt. tube

Page 194: Management on Adnexal Mass

Ectopic gestational sac in the left adnexal region Ectopic gestational sac in the left adnexal region surrounded by a ring of fine near by vessels.surrounded by a ring of fine near by vessels.

Page 195: Management on Adnexal Mass

Rt. interstitial ectopic pregnancy by 3-D trasnvaginal Rt. interstitial ectopic pregnancy by 3-D trasnvaginal sonographysonography

Page 196: Management on Adnexal Mass

Thanks

Page 197: Management on Adnexal Mass
Page 198: Management on Adnexal Mass
Page 199: Management on Adnexal Mass
Page 200: Management on Adnexal Mass
Page 201: Management on Adnexal Mass
Page 202: Management on Adnexal Mass
Page 203: Management on Adnexal Mass
Page 204: Management on Adnexal Mass
Page 205: Management on Adnexal Mass
Page 206: Management on Adnexal Mass
Page 207: Management on Adnexal Mass
Page 208: Management on Adnexal Mass
Page 209: Management on Adnexal Mass

Recommended